← SynDRA
BEVANTOLOL
SynDRA canonical compound SYN0003487 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | ADRB1 |
| Mechanism of action | adrenergic receptor antagonist |
| Indication | angina pectoris | hypertension |
| Disease area | cardiology |
All known targets
Mechanisms of action (all sources)
- adrenergic receptor antagonist
- DRD2 ANTAGONIST
- ADRB1 ANTAGONIST
Drug classes
- Adrenergic Agents
- Adrenergic Antagonists
- Adrenergic beta-1 Receptor Antagonists
- Adrenergic beta-Antagonists
- Neurotransmitter Agents
ATC classes
- C07A · BETA BLOCKING AGENTS
- BETA BLOCKING AGENTS AND THIAZIDES
Cross-references
Synonyms
- calvan
- CI 775
- bevantolol hydrochloride
- bevantolol HCl
- NSC-132348
- Bevantololum
- Bevantolol [INN:BAN]
- Bevantololum [INN-Latin]
- (+-)-bevantolol
- 1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol
- 1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol
- 1-(3,4-dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol
- 1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol
- 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol
- 1-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-3-(3-methylphenoxy)propan-2-ol
- NSC 132348
- CHEBI:238698
- CI-775
- RefChem:119574
- C07AB06
- DTXCID80197265
- 1-((3,4-Dimethoxyphenethyl)amino)-3-(m-tolyloxy)propan-2-ol
- (+/-)-Bevantolol; DL-Bevantolol; NSC 132348
- BRN 2769444
- UNII-34ZXW6ZV21
- (+/-)-bevantolol
- BEVANTOLOL [MI]
- BEVANTOLOL [INN]
- BEVANTOLOL [WHO-DD]
- SCHEMBL49721
- MLS003876814
- orb1688900
- SCHEMBL29688254
- SCHEMBL30536507
- HXLAFSUPPDYFEO-UHFFFAOYSA-N
- HMS3604B08
- HY-A0249
- EBC-08523
Look up BEVANTOLOL in the interactive SynDRA portal →